Related Experiment Video
Updated: Nov 18, 2025

Using the E1A Minigene Tool to Study mRNA Splicing Changes
Published on: April 22, 2021
Long non-coding RNAs MACC1-AS1 and FOXD2-AS1 mediate NSD2-induced cisplatin resistance in esophageal squamous cell
Wenhua Xue1,2, Zhibo Shen1,3,4, Lifeng Li3,4
1Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Abstract:
The nuclear receptor-binding SET domain (NSD) protein family encoding histone lysine methyltransferases is involved in cancer progression. However, the role of NSDs in esophageal squamous cell carcinoma (ESCC) remains unclear. Here we examined the expression of NSDs in cisplatin-resistant and parental ESCC cells and revealed the upregulation of NSD2 in cisplatin-resistant cells. Ectopic expression of NSD2 increased cisplatin resistance and attenuated cisplatin-induced apoptosis. Colony formation assay indicated that NSD2 overexpression enhanced long-term survival of ESCC cells after treatment with cisplatin. In contrast, knockdown of NSD2 inhibited ESCC cell proliferation and sensitized ESCC cells to cisplatin. Depletion of NSD2 augmented the cytotoxic effect of cisplatin on EC109 xenograft tumors. NSD2 stimulated long non-coding RNA MACC1-AS1 in ESCC cells. Knockdown of MACC1-AS1 impaired NSD2-induced cisplatin resistance. Moreover, MACC1-AS1 overexpression promoted ESCC cell proliferation and cisplatin resistance. Clinically, MACC1-AS1 was upregulated in ESCC relative to adjacent noncancerous tissues. High MACC1-AS1 levels were significantly associated with reduced overall survival of ESCC patients. There was a positive correlation between MACC1-AS1 and NSD2 expression in ESCC specimens. Taken together, MACC1-AS1 induced by NSD2 mediates resistance to cisplatin in ESCC and may represent a novel target to improve cisplatin-based chemotherapy.
Insights
Nuclear receptor-binding SET domain protein 2 (NSD2) promotes cisplatin resistance in esophageal squamous cell carcinoma (ESCC) by upregulating MACC1-AS1. Targeting NSD2 and MACC1-AS1 may improve chemotherapy efficacy in ESCC patients.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Nuclear receptor-binding SET domain (NSD) proteins are histone lysine methyltransferases implicated in cancer progression.
- The specific role of NSD proteins in esophageal squamous cell carcinoma (ESCC) and their impact on chemotherapy resistance are not well understood.
Purpose of the Study:
- To investigate the role of NSD proteins, particularly NSD2, in cisplatin resistance in ESCC.
- To elucidate the molecular mechanisms underlying NSD2-mediated cisplatin resistance, focusing on its interaction with long non-coding RNAs.
Main Methods:
- Comparative analysis of NSD protein expression in cisplatin-resistant and parental ESCC cell lines.
- Functional studies involving ectopic expression and knockdown of NSD2 and MACC1-AS1 in ESCC cells.
- Assessment of cisplatin sensitivity, apoptosis, proliferation, and colony formation.
- In vivo studies using EC109 xenograft tumor models.
- Correlation analysis of NSD2 and MACC1-AS1 expression with clinical data from ESCC patients.
Main Results:
- NSD2 was significantly upregulated in cisplatin-resistant ESCC cells.
- Overexpression of NSD2 conferred cisplatin resistance and enhanced cell survival, while NSD2 knockdown sensitized cells to cisplatin.
- NSD2 promoted cisplatin resistance by upregulating the long non-coding RNA MACC1-AS1.
- MACC1-AS1 overexpression also promoted ESCC proliferation and cisplatin resistance.
- Clinically, MACC1-AS1 was upregulated in ESCC tissues and correlated with reduced patient survival, with a positive correlation to NSD2 expression.
Conclusions:
- NSD2 plays a critical role in mediating cisplatin resistance in ESCC, partly through the induction of MACC1-AS1.
- The NSD2-MACC1-AS1 axis represents a potential therapeutic target for overcoming cisplatin resistance in esophageal squamous cell carcinoma.
- Targeting this pathway could enhance the effectiveness of cisplatin-based chemotherapy in ESCC patients.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...

